MAIA Biotechnology (MAIA) Receivables - Other (2021 - 2026)
MAIA Biotechnology (MAIA) recorded Receivables - Other of $50,000 in Q2 2026, down 39.2% from $82,272 a year earlier and down 75.0% from the prior quarter.
Powered by 
Analysis
MAIA Biotechnology (MAIA) Receivables - Other (2021 - 2026) Analysis & Trends
At the end of FY2025, MAIA Biotechnology reported Receivables - Other of $400,000, up 417.1% from FY2024.
- Annual Receivables - Other has a four-year compound annual growth rate of 74.0% (FY2021 to FY2025).
- Across earlier years, Receivables - Other came in at $77,347 in FY2024 (-46.5%), $144,680 in FY2023 (-52.2%), $302,789 in FY2022 (+593.4%) and $43,666 in FY2021.
- The Q2 2026 figure is the lowest quarterly Receivables - Other since Q4 2021.
- On a year-over-year basis, Receivables - Other rose in three of the last eight quarters, with growth averaging 48.1%.
- Peak year-over-year performance for Receivables - Other in the last five years was growth of 593.4% in Q4 2022, against a decline of 55.2% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $200,000 (Q1 2026), $400,000 (Q4 2025) and $82,685 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | MAIA Biotechnology | 69.31 Mn | -12.25 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 82,685.00 |
| Jun 30, 2025 | 82,272.00 |
| Mar 31, 2025 | 78,084.00 |
| Dec 31, 2024 | 77,347.00 |
| Sep 30, 2024 | 53,608.00 |
| Jun 30, 2024 | 177,687.00 |
| Mar 31, 2024 | 155,969.00 |
| Dec 31, 2023 | 144,680.00 |
| Sep 30, 2023 | 114,426.00 |
| Jun 30, 2023 | 386,825.00 |
| Mar 31, 2023 | 348,379.00 |
| Dec 31, 2022 | 302,789.00 |
| Sep 30, 2022 | 255,306.00 |
| Jun 30, 2022 | 203,158.00 |
| Dec 31, 2021 | 43,666.00 |
API Access
MAIA Biotechnology Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=MAIA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "MAIA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=MAIA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();